Premier Alternatives

Magnolia Medical Technologies

Seattle, WA · Founded 2006 · Privately Held (backing)

Developer of a blood-collection system designed to eliminate sepsis misdiagnosis due to the preventable error of false-positive blood culture results caused by contamination. Magnolia Medical Technologies is based in Seattle, WA and was founded in 2006. It was valued at $244 million at its growth round in Jan 2025, the last priced event on record. It has raised $184 million across 6 recorded rounds; the latest was a $43.4 million early-stage round in Jan 2022.

PMV mark · valuation
$244.0M
Oct 2026
Priced at
its growth round
Jan 2025
Total raised
$183.9M
Last round
Early Stage VC
Jan 2022

Magnolia Medical Technologies key facts

as of Oct 2026
  • Developer of a blood-collection system designed to eliminate sepsis misdiagnosis due to the preventable error of false-positive blood culture results caused by contamination.
  • Magnolia Medical Technologies is valued at approximately $244.0M as of Oct 2026, set at its growth round, Jan 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $183.9M across 6 recorded rounds; the latest was Early Stage VC ($43.4M) in Jan 2022.
  • Notable investors include Band of Angels, Lauder Partners, RTW Investments, Vivo Capital, HealthQuest Capital — 22 tracked in total.
  • Magnolia Medical Technologies has filed 10 Form Ds with the SEC since 2011, most recently Jan 2022 ($43.4M sold to 18 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$244.0M

Valued at $244.0M at its growth round, Jan 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Magnolia Medical Technologies with a free account
  • ·The complete investor list: 22 names
  • ·Watch Magnolia Medical Technologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Magnolia Medical Technologies funding rounds

6 rounds
Jan 2022Early Stage VC$43.4MSEC filing▮
Dec 2018Early Stage VC$19.6MSEC filing▮
Jun 2016Early Stage VC$21.0MSEC filing▮
Feb 2016Debt$1.4MSEC filing▮
May 2015Early Stage VC$6.2MSEC filing▮
Full funding history →

Magnolia Medical Technologies valuation

Magnolia Medical Technologies was valued at $244 million at its growth round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Magnolia Medical Technologies raised?

Magnolia Medical Technologies has raised $184 million across 6 recorded rounds since 2013. The largest was a $6.2 million early-stage round in May 2015; the most recent was a $43.4 million early-stage round in Jan 2022.

Magnolia Medical Technologies has filed 10 Form Ds with the SEC since 2011, most recently in Jan 2022 ($43.4 million sold to 18 investors).

Magnolia Medical Technologies investors

22 investors are on record for Magnolia Medical Technologies, including Band of Angels, Lauder Partners, RTW Investments and Vivo Capital. The early-stage round in Jan 2022 drew 18 investors.

About Magnolia Medical Technologies

Developer of a blood-collection system designed to eliminate sepsis misdiagnosis due to the preventable error of false-positive blood culture results caused by contamination. The company's system is pre-assembled and sterile to actively divert and sequester the initial blood that is known to contain contaminants, then blood cultures are collected through an independent, second flow path, creating a closed vein-to-bottle collection system to prevent bypassing diversion, enabling medical professionals to achieve improved outcomes for all patients, reduce hospital costs and battle the global threat of antibiotic resistance.

Sector
Healthcare
HQ
Seattle, WA, United States
Founded
2006
Employees
84
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.